We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Events

02 Jun 2026 - 04 Jun 2026
17 Jun 2026 - 19 Jun 2026

Microbial Identification System Identifies Cause of Bacterial Contamination

By LabMedica International staff writers
Posted on 03 Sep 2009
An identification system, which can identify 1,044 species of bacterium, solved a contamination problem in a renal dialysis center.

Doctors and scientists first tried unsuccessfully to identify the bacterium causing contamination in a renal care center (San Jose, CA, USA) using a standard hospital microbial identification system. More...
The microbial identification systems routinely used by hospitals can only identify about 300 bacterial species.

The investigating team from Stanford University (Palo Alto, CA, USA), then used Biolog's (Hayward, CA, USA) GEN III system and identified the contaminant in the renal care center as a Halomonas bacterium. The GEN III system is an easy system to use as it is built around a single test panel that can identify both Gram-negative and Gram-positive bacteria without a Gram stain. The finding was verified by 16s ribosomal DNA (rDNA) sequencing, a more complicated and costly molecular identification method.

Biolog has microbiology test kits capable of identifying environmental as well as known pathogenic bacteria species infecting humans, animals, and even plants. The bacterial contaminant Halomonas is typically found in high salt environments such as salt ponds. Normally, one would not expect to find this bacterium in a hospital clinic. In this case, the investigators believe that the bacterium was a contaminant of the sodium bicarbonate solutions that are routinely used to prepare dialysis fluid.

"Bacteria are enterprising, and they will get into and thrive in any environment that they can adapt to and grow in,” said Barry Bochner, Ph.D., CEO and CSO at Biolog "This is why it is important for microbiology labs to use identification methods with broader capabilities. It is not reasonable to assume that environmental bacteria will not find ways to cause contamination and infections.”

Biolog is a privately held company that develops new cell analysis tools for solving critical medical laboratory, pharmaceutical, and biotechnological problems.

The findings were published in July 2009 in the journal Medicine.

Related Links:
Stanford University
Biolog



Gold Member
Aspiration System
VACUSAFE
Online QC Software
Acusera 24•7
HIV-1 Molecular Diagnostic Assay
AltoStar HIV RT-PCR Kit 1.5
Prefilled Tubes
Prefilled 5.0ml Tubes
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The updated CRC screening guidance adds a stool RNA test and an updated stool DNA test to the menu of preferred options (image credit: Adobe Stock)

Updated Guidance Prioritizes Stool-Based Colorectal Cancer Screening Tests

Colorectal cancer is the second-leading cause of cancer death in the United States and claimed an estimated 55,000 lives in 2026. Incidence is rising among adults younger than 50, even as overall mortality... Read more

Immunology

view channel
Image: Study design for analysis of monocyte phenotype, function, and metabolism (Gráinne Jameson et al., Journal of Infection (2026). DOI: 10.1016/j.jinf.2026.106755)

Metabolic Biomarker Distinguishes Latent from Active Tuberculosis and Tracks Treatment Response

Tuberculosis (TB) remains the world’s leading infectious killer, with 10.8 million cases and 1.25 million deaths recorded globally in 2023. Yet many infected individuals never develop active disease, underscoring... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.